Social Activist Demands Lab Testing Of Ayurvedic Medicine Used For Joint Pains

Jammu: (UNI) A Jammu based social activist Sukesh C Khajuria has sought laboratory testing of Ayurvedic medicine, being used for treating the joint pains.

The social activist had expressed his apprehensions related to the Ayurvedic composition known as ‘Batnashak Batika”, which he claimed is increasingly being utilized for the treatment of joint pains, particularly in patients who have suffered from ‘Chikungunya’ in Jammu and Kashmir. He wrote to the drug authorities in J&K that ‘Batnashak Batika’ reportedly demonstrates swift efficacy in alleviating post-Chikungunya joint pains, contrary to the conventional understanding that Ayurvedic herbal medicines typically facilitate gradual healing and recovery.

Given the remarkable and expeditious healing attributed to this Ayurvedic medicine, I harbour reservations regarding its composition,” he added.

He requested the Drug controller Jammu and Kashmir to conduct a thorough chemical examination of the composition to determine whether any steroids or potentially harmful substances have been incorporated to expedite relief, posing potential health risks to consumers. Khajuria and urged the authorities for a comprehensive chemical examination of the Ayurvedic medicine at the drug laboratory and disseminate the findings to the general public for the collective benefit of society.

He said he had alerted the drug authorities of Jammu and Kashmir, Union Health Minister and other central and union territory officials about the dangers of sale of such drugs.

Related Posts

  • Pharma
  • April 21, 2025
  • 99 views
UPSIDA offers plots for pharma manufacturing units in Lalitpur

Lucknow:  To encourage investment in the pharmaceutical industry, the Uttar Pradesh State Industrial Development Authority (UPSIDA) launched a project for the allocation of industrial plots under the ‘Bulk Drug and…

  • Pharma
  • April 21, 2025
  • 23 views
Rigaku Partners with SPERA PHARMA to Boost Pharmaceutical Development

Rigaku Corporation, a Group company of Rigaku Holdings Corporation, and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

UPSIDA offers plots for pharma manufacturing units in Lalitpur

UPSIDA offers plots for pharma manufacturing units in Lalitpur

Rigaku Partners with SPERA PHARMA to Boost Pharmaceutical Development

Rigaku Partners with SPERA PHARMA to Boost Pharmaceutical Development

Three drug smugglers arrested in South Salmara-Mankachar

Three drug smugglers arrested in South Salmara-Mankachar

Man accused of sexually harassing air hostess in Gurugram hospital arrested

Man accused of sexually harassing air hostess in Gurugram hospital arrested